Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 1.000 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.501 | |
3vnt | 0JA | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.475 | |
3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.458 | |
4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.454 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.447 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.444 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 |